UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q
(Mark One)

[X]   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

                        For the quarterly period ended June 30, 2009

[  ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

                 For the transition period from _____ to _______

                          Commission File Number: None

                          TONGJI HEALTHCARE GROUP, INC.
                ------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

           Nevada                                None
-------------------------------           -------------------
(State or other jurisdiction of            (I.R.S. Employer
 incorporation or organization)           Identification No.)

                                No. 5 Beiji Road
                             Nanning, Guangxi, China
                      ------------------------------------
               (Address of Principal Executive Offices) (Zip Code)

       Registrant's telephone number including area code: 0086-771-2020000

                                       N/A
     ----------------------------------------------------------------------
         Former name, former address, and former fiscal year, if changed
                                since last report

Indicate by check mark whether the registrant (1) filed all reports  required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the past 12 months (or for such shorter  period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a smaller reporting company. See
definition  of "large  accelerated  filer",  "accelerated  filer"  and  "smaller
reporting company" in Rule 12b-2 of the Exchange Act.

Larger accelerated filer [  ]                   Accelerated filer [  ]
Non-accelerated filer [  ]          Smaller reporting company [X]

Indicate by check mark whether registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes [ ]    No [X]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable date:  15,812,391 shares outstanding
as of August 10, 2009.

<PAGE>

                          TONGJI HEALTHCARE GROUP, INC.
                           CONSOLIDATED BALANCE SHEETS
                    AS OF JUNE 30, 2009 AND DECEMBER 31, 2008
                                   (UNAUDITED)

                                               June 30, 2009   December 31, 2008
                                               -------------   -----------------

                             ASSETS
Current Assets
 Cash and cash equivalents                     $    35,057       $    61,826
 Accounts receivable,  net                         257,717           267,574
 Due from related parties                           54,861           268,815
 Medicine supplies                                  93,249           144,746
 Prepaid expenses and other current assets          90,702           128,761
                                               ------------      ------------
Total Current Assets                               531,586           871,722

Property, Plant and Equipment, net               4,689,911         4,323,445

Capital Lease Deposit                              153,401           153,903
                                               ------------      ------------
TOTAL ASSETS                                   $ 5,374,898       $ 5,349,070
                                               ============      ============

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities
 Accounts payable and accrued expenses         $   428,898       $   240,528
 Due to related parties                          3,920,536         3,367,857
 Other payable                                     195,260           351,499
 Deferred gain on sale & lease back                111,183           111,547
 Capital lease obligation-short term               358,321           343,527
                                               ------------      ------------
Total Current Liabilities                        5,014,198         4,414,958

Long Term Liabilities
 Capital lease obligation                          159,572           343,922
 Deferred gain on sale & lease back                 46,012           101,936
                                               ------------      ------------
Total Long Term Liabilities                        205,584           445,858
                                               ------------      ------------

Total Liabilities                                5,219,782         4,860,816

STOCKHOLDERS' EQUITY
 Preferred stocks; $0.001 par value,
  20,000,000 shares authorized and 0
  share issued and outstanding                           -                 -
 Common stocks; $0.001 par value,
  100,000,000 shares authorized and
  15,812,391 and 15,812,391  shares
  issued and outstanding as of June 30, 2009
  and December 31, 2008 respectively                15,813            15,813
 Additional paid in capital                        424,967           424,967
 Statutory reserve                                  41,812            41,812
 Accumulated Deficit                              (402,351)          (70,727)
 Accumulated other comprehensive income             74,874            76,389
                                               ------------      ------------

Total Stockholders' Equity                         155,116           488,254
                                               ------------      ------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY     $ 5,374,898       $ 5,349,070
                                               ============      ============

The  accompanying  notes are an integral  part of these  unaudited  consolidated
financial statements.


                                       1
<PAGE>

                          TONGJI HEALTHCARE GROUP, INC.
      CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME
        FOR THE THREE AND SIX MONTH PERIODS ENDED JUNE 30, 2009 AND 2008
                                   (UNAUDITED)

<TABLE>
<S>                                     <C>         <C>          <C>             <C>

                                      For the three month          For the six month
                                         periods ended               periods ended
                                            June 30,                   June 30,
                                       2009         2008         2009            2008
                                     --------     --------     --------        --------

OPERATING REVENUE
    Patient service revenue        $  160,038    $  443,441   $  316,390     $  560,892
    Other operating revenue           283,068       268,759      552,110        734,417
                                   -----------   -----------  -----------    -----------
    Total operating revenue           443,106       712,200      868,500      1,295,309

OPERATING EXPENSES
    Selling, general and
     adminstrative expenses           154,498       205,104      434,853        445,685
    Medicine and supplies             219,071       268,759      462,638        568,547
    Depreciation expenses              81,392        96,879      178,646        190,115
                                   -----------   -----------  -----------    -----------
    Total operating expenses          454,961       570,742    1,076,137      1,204,347
                                   -----------   -----------  -----------    -----------

INCOME (LOSS) FROM OPERATIONS         (11,854)      141,459     (207,636)        90,962

OTHER INCOME (EXPENSE)

    Other income (expense)              1,457        (1,755)       2,225           (798)
    Interest expense, net of income   (63,730)       (5,340)    (126,212)       (90,912)
                                   -----------   -----------  -----------    -----------
        Total Other Expense           (62,273)       (7,095)    (123,987)       (91,710)
                                   -----------   -----------  -----------    -----------
NET INCOME (LOSS)                     (74,128)      134,364     (331,624)          (748)
                                   -----------   -----------  -----------    -----------
Foreign currency translation
 gain (loss)                              170        14,616       (1,514)        32,291
                                   -----------   -----------  -----------    -----------
COMPREHENSIVE INCOME (LOSS)        $  (73,957)   $  148,980   $ (333,137)    $   31,543
                                   ===========   ===========  ===========    ===========
NET INCOME (LOSS) PER BASIC
AND DILUTED SHARES                 $   (0.005)   $    0.009   $   (0.021)    $   (0.000)
                                   ===========   ===========  ===========    ===========
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING          15,812,391    15,759,698   15,812,391     15,706,128
                                   ===========   ===========  ===========    ===========
</TABLE>


The  accompanying  notes are an integral  part of these  unaudited  consolidated
financial statements.


                                       2
<PAGE>

                          TONJI HEALTHCARE GROUP, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
             FOR THE SIX MONTH PERIODS ENDED JUNE 30, 2009 AND 2008
                                   (UNAUDITED)

                                                          2009           2008
                                                        --------       --------
Cash flows from operating activities:
  Net loss                                           $  (331,624)    $     (748)
  Adjustments to reconcile net loss to
  Net cash provided by (used in) operating
  activities:
   Depreciation and amortization                         178,646        190,115
   Allowance for doubtful accounts                        42,165              -
   Increase/(decrease) in assets and liabilities:
     Accounts receivable                                   8,987        (52,171)
     Inventory                                            51,038         59,318
     Prepaid expense and other current assets             (4,517)      (103,589)
     Accounts payable and accrued expenses               180,244        (14,672)
     Unearned revenue                                    (55,604)       (53,921)
     Other payables                                     (146,177)        58,282
                                                     ------------   ------------
                   Total adjustment                      124,782         83,362
                                                     ------------   ------------
Net Cash Provided By (Used in) Operating Activities     (206,842)        82,614
                                                     ------------   ------------
Cash flows from investing activities:
  (Acquisitions) of fixed assets                          (9,046)        (2,391)
  Disposals of fixed assets                                7,306              -
  Payments for construction and lease back              (427,545)    (1,797,416)
  Due from related parties                               213,127        690,731
                                                     ------------   ------------
Net Cash Used in Investing Activities                   (216,158)    (1,109,076)
                                                     ------------   ------------
Cash flows from financing activities:
  Payments of capital lease                             (167,354)      (148,369)
  Due to related parties                                 563,781      1,210,109
                                                     ------------   ------------

Net Cash Provided by Financing Activities                396,426      1,061,740
                                                     ------------   ------------
Effects of foreign currency translation                     (195)         2,486
                                                     ------------   ------------
Net Increase (decrease) in Cash and Cash Equivalents     (26,769)        37,764

Cash and Cash Equivalents-Beginning of Period             61,826         23,165
                                                     ------------   ------------
Cash and Cash Equivalents-Ending of Period           $    35,057    $    60,929
                                                     ============   ============
Cash Paid During the Year for:
  Income taxes                                       $         -    $         -
                                                     ============   ============
  Interest paid                                      $   126,249    $   118,733
                                                     ============   ============

Supplemental disclosures for non cash financing
 activities
   Shares issued against subscription receivable     $         -    $    77,780
                                                     ============   ============
   Shares cancelled                                  $         -    $        18
                                                     ============   ============

The  accompanying  notes are an integral  part of these  unaudited  consolidated
financial statements.


                                       3
<PAGE>

                               TONGJI HEALTHCARE GROUP, INC.
                    NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
                                       JUNE 30, 2009

NOTE 1- ORGANIZATION AND BASIS OF PRESENTATION

Nanning Tongji Hospital, Inc. ("NTH") was established in Nanning in the province
of Guangxi of the  Peoples  Republic  of China  ("PRC")  by the  Nanning  Tongji
Medical Co. Ltd. and an individual on October 30, 2003.

NTH is an assigned hospital for medical insurance in City of Nanning and Guangxi
Province.  NTH contains specialties in the areas of internal medicine,  surgery,
gynecology, pediatrics, emergency medicine, ophthalmology,  medical cosmetology,
rehabilitation,   dermatology,  otolaryngology,  traditional  Chinese  medicine,
medical imaging, anesthesia,  acupuncture, physical therapy, health examination,
and prevention.

On December 19, 2006, the officers of NTH filed Articles of Incorporation in the
State of  Nevada  which was  approved  on  December  19,  2006 to create  Tongji
Healthcare Group, Inc. a Nevada corporation (the "Company") and also established
Tongji, Inc., a Colorado corporation ("Tongji") a wholly owned subsidiary of the
Company.

On December 27, 2006,  Tongji  acquired 100% of the equity in NTH pursuant to an
Agreement and Plan of.  Pursuant to the acquisition of NTH, it became the wholly
owned subsidiary of Tongji.  The Company  incorporated with 50,000,000 shares of
common stock and 20,000,000  shares of preferred  stock both with a par value of
$0.001. The Company issued 15,652,557 shares of common stock to the shareholders
of NTH in  exchange  for  100% of the  issued  and  outstanding  shares  of NTH.
Thereafter  and for  purposes of these  consolidated  financial  statements  the
"Company"  and  "NTH"  are used to refer to the  operations  of  Nanning  Tongji
Hospital Co. Ltd.

The  acquisition  of NTH was  accounted for as a reverse  acquisition  under the
purchase method of accounting  since the shareholders of NTH obtained control of
the consolidated  entity.  Accordingly,  the reorganization of the two companies
was  recorded  as a  recapitalization  of NTH,  with NTH  being  treated  as the
continuing operating entity.

According to the PRC Regulation of Healthcare  Institutions,  hospitals shall be
subject to register with the Administration of Health of the local government to
obtain their license for hospital  service  operation.  The Company received its
renewed  operation  license from  Nanning's  government in May of 2005, and this
license remains valid until the next scheduled renewing date of May 2009.

Other existing  regulations  having material  effects on the Company's  business
include  those  dealing  with  physician's  licensing,  usage  of  medicine  and
injection, public security in health and medical advertising.

As the Company  maintains a facility with an excess of 100 beds,  they must have
their license renewed at least every three years.  The Company is also obligated
to provide free service or dispatch  their  physicians  or employees  for public
assistance.  The Company has a very small  percentage  of their service for this
area.


                                       4
<PAGE>


NOTE 2- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The  accompanying  unaudited  financial  statements  of the  Company  have  been
prepared in accordance with generally accepted accounting principles for interim
financial information.  Accordingly,  they do not include all of the information
required by generally  accepted  accounting  principles  for complete  financial
statements. In the opinion of management,  all adjustments (consisting of normal
recurring  adjustments)  considered  necessary for a fair presentation have been
included.  Operating  results  for  the  interim  periods  are  not  necessarily
indicative of the results for any future period. These statements should be read
in conjunction with the Company's audited financial statements and notes thereto
for the fiscal year ended December 31, 2008. The results of the six month period
ended June 30, 2009 are not necessarily indicative of the results to be expected
for the full fiscal year ending December 31, 2009.

Principles of Consolidation

The consolidated  financial statements include the accounts of Tongji Healthcare
Group, Inc. and its wholly owned  subsidiaries  Tongji,  Inc. and Nanning Tongji
Hospital, Inc. All significant  intercompany accounts and transactions have been
eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting  period.  On an on-going basis,  the Company  evaluates its
estimates,  including,  but not limited to, those related to  depreciation,  bad
debts,  income taxes and  contingencies.  Actual results could differ from those
estimates.

Foreign Currency Translation

The  Company's  functional  currency  is that of the PRC  which  is the  Chinese
Renminbi  (RMB).  The  reporting  currency  is  that of the US  Dollar.  Capital
accounts of the  consolidated  financial  statements are translated  into United
States  dollars  from RMB at their  historical  exchange  rates when the capital
transactions  occurred.  Assets and  liabilities  are translated at the exchange
rates as of the balance sheet date.  Income and  expenditures  are translated at
the average  exchange rate of the year. The RMB is not freely  convertible  into
foreign currency and all foreign currency exchange  transactions must take place
through authorized institutions.  No representation is made that the RMB amounts
could  have  been,  or could be,  converted  into US dollar at the rates used in
translation.

The  Company  records  these   translation   adjustments  as  accumulated  other
comprehensive income (loss). Gains and losses from foreign currency transactions
are included in other income (expense) in the results of operations. For the six
month periods ended June 30, 2009 and 2008, the Company  recorded  approximately
$(1,520)  and  $32,291  in  transaction  gains  (loss) as a result  of  currency
translation.

Revenue Recognition

The  Company's  revenue  recognition  policies  are  in  compliance  with  Staff
Accounting  Bulletin  (SAB)  104.  Sales  revenue is  recognized  at the date of
shipment to customers or services has been  rendered  when a formal  arrangement
exists, the price is fixed or determinable,  the delivery is completed, no other


                                       5
<PAGE>

significant  obligations of the Company exist and  collectibility  is reasonably
assured.  Payments  received  before all of the  relevant  criteria  for revenue
recognition are satisfied are recorded as unearned revenue.

The  Company  generates  revenue  from the  individuals  as well as  third-party
payers,  including PRC government programs and insurance providers,  under which
the  hospital is paid based upon  several  methodologies  including  established
charges,  the cost of providing  services,  predetermined  rates per  diagnosis,
fixed  per diem  rates or  discounts  from  established  charges.  Revenues  are
recorded at  estimated  net amounts due from  patients,  third-party  payers and
others for  healthcare  services  provided at the time the service is  provided.
Revenues  for  pharmaceutical  drug  sales are  recognized  upon the drug  being
administered  to a patient or at the time a prescription is filled for a patient
that contain an executed prescription slip by a registered physician.

Revenues are recorded at estimated net amounts due from patients and  government
Medicare funds. The Company's  accounting system calculates the expected amounts
payable  by the  government  Medicare  funds.  The  Company  bills for  services
provided to Medicare  patients  through a medical card (the US  equivalent to an
insurance card).  The Company normally  receives 90% of the billed amount within
90 days with the  remaining  10% upon approval by the end of the year by the PRC
government.  However,  there have not been significant  differences  between the
amounts  the  Company  bills  the  government  Medicare  funds  and the  amounts
collected from the Medicare funds.

Accounts Receivable

Accounts  receivable are recorded at the estimated net  realizable  amounts from
government units, insurance companies and patients.  Generally,  the third-party
payers  reimburse the Company on a 30-day cycle,  so collections for the Company
has  historically  not been considered to be an area that exposes the Company to
additional  risk.  Hospital staff does perform  verification of patient coverage
prior to examinations and/or procedures taking place

For  any  Medicare  patient  who  visits  the  hospital  that is  qualified  for
acceptance, the hospital will only include the portion that the social insurance
organization  in the accounts  receivable  and collects the self-pay  portion in
cash at the time of the service.  At times, the pre-determined rate the hospital
will  charge  may be  different  than  the  approved  Medicare  rate,  thus  the
likelihood  of some bad debt can occur.  Management  continues to evaluate  this
estimate on an ongoing basis.

The Company has established a reserve for  uncollectibles of $59,779 and $59,975
as of June 30, 2009 and December 31, 2008.

Prepaid expenses and other current assets

Prepaid  expenses and other current assets consisted of the following as of June
30, 2009 and December 31, 2008:

                           March 31, 2009       December 31,2008
                           --------------       ----------------

Other receivable              $  7,348              $ 54,364
Advance to suppliers            10,781                38,486
Prepaid expenses                72,573                35,910
Total                         $ 90,702              $128,761

Prepaid  expenses include amounts paid for the business plan and design fees for
a new hospital under construction.


                                       6
<PAGE>

Advertising Costs

The  Company  expenses  the  costs  associated  with  advertising  as  incurred.
Advertising  expenses for the six month  periods ended June 30, 2009 and 2008 of
$34,319 and  $107,132,  respectively  are  included  in selling and  promotional
expenses  in the  statements  of income.  Advertising  costs  include  marketing
brochures and an advertising campaign to the public.

Impairment of Long-Lived Assets

Effective January 1, 2002, the Company adopted Statement of Financial Accounting
Standards  No. 144,  "Accounting  for the  Impairment  or Disposal of Long-Lived
Assets" ("SFAS 144"), which addresses financial accounting and reporting for the
impairment  or  disposal  of  long-lived  assets and  supersedes  SFAS No.  121,
"Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to
be Disposed Of," and the accounting and reporting  provisions of APB Opinion No.
30,  "Reporting  the  Results of  Operations  for a  Disposal  of a Segment of a
Business." The Company  periodically  evaluates the carrying value of long-lived
assets  to be held and used in  accordance  with  SFAS  144.  SFAS 144  requires
impairment  losses to be recorded on long-lived  assets used in operations  when
indicators of impairment are present and the  undiscounted  cash flows estimated
to be generated by those assets are less than the assets' carrying  amounts.  In
that  event,  a loss is  recognized  based on the  amount by which the  carrying
amount  exceeds  the  fair  market  value  of the  long-lived  assets.  Loss  on
long-lived  assets to be disposed of is determined in a similar  manner,  except
that fair  market  values are  reduced  for the cost of  disposal.  Based on its
review,  the Company  believes  that,  as of June 30, 2009 and December 31, 2008
there were no significant impairments of its long-lived assets.

Earnings (Loss) Per Share of Common Stock

Earnings per share is calculated  in accordance  with the Statement of financial
accounting  standards No. 128 (SFAS No. 128), "Earnings per share". SFAS No. 128
superseded  Accounting  Principles  Board  Opinion  No.15 (APB 15). Net loss per
share for all periods  presented  has been  restated to reflect the  adoption of
SFAS No. 128. Basic net loss per share is based upon the weighted average number
of  common  shares  outstanding.  Diluted  net  loss  per  share is based on the
assumption that all dilutive convertible shares and stock options were converted
or exercised.  Dilution is computed by applying the treasury stock method. Under
this method,  options and warrants are assumed to be exercised at the  beginning
of the period (or at the time of issuance,  if later),  and as if funds obtained
thereby were used to purchase  common  stock at the average  market price during
the period.

The Company has not  granted  any options or warrants  during 2009 or 2008,  and
there are no options or warrants  outstanding  as of June 30, 2009 and  December
31, 2008.

Income Taxes

The Company utilizes SFAS No. 109, "Accounting for Income Taxes," which requires
the  recognition of deferred tax assets and  liabilities for the expected future
tax  consequences of events that have been included in the financial  statements
or tax returns. Under this method,  deferred income taxes are recognized for the
tax consequences in future years of differences  between the tax bases of assets


                                       7
<PAGE>

and liabilities and their financial  reporting  amounts at each period end based
on enacted tax laws and statutory  tax rates  applicable to the periods in which
the differences are expected to affect taxable income.  Valuation allowances are
established,  when  necessary,  to reduce  deferred  tax  assets  to the  amount
expected to be realized.

In  accordance  with the  relevant tax laws and  regulations  of PRC and US, the
corporation  income tax rate would  typically be 33% in the PRC. The Company has
received a waiver (duty free certificate) from the taxing authorities in the PRC
for  corporate  enterprise  income  tax for the year ended  2004  through  2006.
Effective 2007, the Company will be taxed at the rate of 33%.

Beginning  January 1, 2008, the new Enterprise Income Tax (EIT) law will replace
the  existing  laws  for  Domestic   Enterprises   (DES)  and  Foreign  Invested
Enterprises  (FIEs).  The new standard EIT rate of 25% will replace the 33% rate
currently applicable to both DES and FIEs.

In addition,  companies in the PRC are required to pay business taxes consisting
of  5%  of  income  they  derive  from  providing  medical  treatment  and  city
construction taxes, and educational taxes are based on 7% and 3% of the business
taxes,  and the  Company  had  accrued  these  taxes for 2005.  The  Company has
received notification that they are exempt from these taxes for the years ending
2006 through 2008.  The company  become normal  taxpayer in 2009 and need to pay
the above taxes.

Segment Information

Statement of Financial  Accounting  Standards No. 131 ("SFAS 131"),  "Disclosure
About  Segments of an Enterprise  and Related  Information"  requires use of the
"management approach" model for segment reporting. The management approach model
is based on the way a company's management organizes segments within the company
for making operating  decisions and assessing  performance.  Reportable segments
are based on products  and  services,  geography,  legal  structure,  management
structure, or any other manner in which management disaggregates a company. SFAS
131 has no effect on the  Company's  consolidated  financial  statements  as the
Company  consists  of one  reportable  business  segment.  All  revenue  is from
customers in People's Republic of China. All of the Company's assets are located
in People's Republic of China.

Recent Accounting Pronouncements

On  December   30,  2008  FASB  issued  FIN  48-3,   "Effective   Date  of  FASB
Interpretation  No. 48 for Certain Nonpublic  Enterprises".  This FSP defers the
effective date of FASB  Interpretation  No. 48,  Accounting  for  Uncertainty in
Income Taxes, for certain non-public enterprises as defined in paragraph 289, as
amended,  of FASB  Statement No. 109,  Accounting  for Income  Taxes,  including
non-public  not-for-profit   organizations.   However,  non-public  consolidated
entities of public  enterprises  that apply U. S. GAAP are not  eligible for the
deferral. Nonpublic enterprises that have applied the recognition,  measurement,
and disclosure provisions of Interpretation 48 in a full set of annual financial
statements  issued  prior to the  issuance of this FSP also are not eligible for
the deferral.  This FSP shall be effective upon  issuance.  The Company does not
believe this pronouncement will impact its financial statements.

In January 2009, the FASB issued FSP EITF 99-20-1, "Amendments to the Impairment
Guidance  of EITF Issue No.  99-20,  and EITF Issue No.  99-20,  Recognition  of
Interest Income and Impairment on Purchased and Retained Beneficial Interests in
Securitized Financial Assets" ("FSP EITF 99-20-1"). FSP EITF 99-20-1 changes the
impairment  model  included  within  EITF 99-20 to be more  consistent  with the
impairment models of FAS No. 115. FSP EITF 99-20-1 achieves this by amending the
impairment  model in EITF  99-20 to remove  its  exclusive  reliance  on "market
participant"  estimates  of future  cash flows used in  determining  fair value.
Changing the cash flows used to analyze other-than-temporary impairment from the
"market  participant"  view to a holder's  estimate of whether  there has been a
"probable"  adverse  change in estimated  cash flows  allows  companies to apply
reasonable judgment in assessing whether an other-than-temporary  impairment has


                                       8
<PAGE>

occurred.  The adoption of FSP EITF  99-20-1 will not have a material  impact on
the Company's consolidated financial statements.

In June 2009,  the FASB  issued  SFAS No.  166,  "Accounting  for  Transfers  of
Financial Assets -- an amendment of FASB Statement No. 140" ("SFAS 166"),  which
requires  additional   information  regarding  transfers  of  financial  assets,
including  securitization  transactions,  and where  companies  have  continuing
exposure  to the  risks  related  to  transferred  financial  assets.  SFAS  166
eliminates  the concept of a "qualifying  special-purpose  entity,"  changes the
requirements  for  derecognizing   financial  assets,  and  requires  additional
disclosures. SFAS 166 is effective for fiscal years beginning after November 15,
2009.

In June 2009, the FASB issued SFAS No. 167,  "Amendments to FASB  Interpretation
No. 46(R)" ("SFAS 167"),  which modifies how a company determines when an entity
that is  insufficiently  capitalized  or is not  controlled  through  voting (or
similar   rights)   should  be   consolidated.   SFAS  167  clarifies  that  the
determination of whether a company is required to consolidate an entity is based
on, among other things,  an entity's purpose and design and a company's  ability
to direct  the  activities  of the  entity  that most  significantly  impact the
entity's  economic  performance.  SFAS 167 requires an ongoing  reassessment  of
whether a company is the primary beneficiary of a variable interest entity. SFAS
167 also  requires  additional  disclosures  about a  company's  involvement  in
variable interest  entities and any significant  changes in risk exposure due to
that  involvement.  SFAS 167 is  effective  for  fiscal  years  beginning  after
November 15, 2009.

In June 2009,  the FASB  issued  SFAS No.  168,  The FASB  Accounting  Standards
Codification TM and the Hierarchy of Generally  Accepted  Accounting  Principles
("SFAS No. 168"),  which becomes  effective for financial  statements issued for
interim  and annual  periods  ending  after  September  15,  2009.  SFAS No. 168
replaces  SFAS  No.  162,  The  Hierarchy  of  Generally   Accepted   Accounting
Principles. SFAS No. 168 identifies the sources of accounting principles and the
framework  for  selecting  principles  used  in  the  preparation  of  financial
statements of nongovernmental  entities that are presented in conformity with US
GAAP (the GAAP hierarchy).

NOTE 3- PROPERTY & EQUIPMENT

Property & equipment  as of June 30, 2009 and  December  31, 2008  comprised  of
following:


                            Estimated         June 30,     December 31,
                           Useful Lives        2009             2008
                             (Years)

Office equipment               5-10          $   73,317    $   80,320
Medical equipment               5             1,103,259      ,103,494
Fixtures                        10              111,128       106,353
Vehicles                        5                40,680        40,813
Construction in Progress                      3,959,997     3,544,097
                                             -----------   -----------

                                              5,288,381      4,875,077

Less: accumulated depreciation                 (598,470)     (551,632)
                                             -----------   -----------
Property and equipment, net                  $4,689,911    $4,323,445
                                             ===========   ===========


                                       9
<PAGE>

Depreciation expense charged to operations was $178,646 and $190,115 for the six
month periods ended June 30, 2009 and 2008, respectively.

NOTE 4- MEDICINE SUPPLIES

Medicine  supplies  consisted of the  following as of June 30, 2009 and December
31, 2008, 2007:

                             June 30, 2009       December 31,2008
                             -------------       ----------------

Western medicine                $85,944               $  3,543
Traditional Chinese medicine      7,305                141,203
Total                          $ 93,249               $144,746

NOTE 5 - MAJOR CUSTOMERS AND SUPPLIERS

The Company had one  supplier  that  accounted  for 67% of purchase  for the six
month periods ended June 30, 2009. Accounts payable from this major supplier was
$109,047 as of June 30, 2009.

The Company does not have any major  customers  for the six month  periods ended
June 30, 2009 as the customers are mostly patients.

NOTE 6- CAPITAL LEASE OBLIGATIONS:

Lease Deposit

The lease  deposit as of June 30, 2009 and December  31, 2008 and were  $153,401
and $153,903 respectively. It will be due in November 2010.

Deferred Gain on Sale and Lease Back

The  total  gain on sale and  lease  back  was  $333,549.  According  to SFAS 13
"Accounting  for Leases" this gain is deferred and amortized over the Lease term
of 36 months. Accordingly,  $55,604 and $53,922 were amortized for the six month
periods ended June 30, 2009 and 2008 respectively.

The deferred revenue  outstanding as of June 30, 2009 and December 31, 2008 were
as follows:

                     June 30, 2009          December 31, 2008

       Current         $ 111,183                $111,547
       Long term          46,012                101,936
                     ------------            ------------
                       $ 157,195                $213,483
                     ------------            ------------

Capital Lease Obligations

In 2007, the Company leased various  equipments under capital leases expiring in
2010. The assets and liabilities  under capital leases are recorded at the lower
of the  present  value of the  minimum  lease  payments or the fair value of the
asset.  The assets are depreciated  over the lesser of their related lease terms


                                       10
<PAGE>

or their estimated productive lives. Depreciation of assets under capital leases
was included in  depreciation  expense for the six month  periods ended June 30,
2009.

Aggregate minimum future lease payments under capital leases for next five years
after June 30, 2009 are as follows:

2009                         $  390,821
2010                            162,842
                              ----------
  Total                      $  553,663
                             ===========

Capital lease obligations  represent the following at June 30, 2009 and December
31, 2008:

                                               June 30, 2009   December 31, 2008
                                               -------------   -----------------
Total minimum lease payments                   $    553,662      $    751,521
Less : Interest expense relating to future
periods                                             (35,769)          (64,073)
                                               -------------     -------------
Present value of the minimum lease payments         517,893           687,448
Less: current portion                               358,321          (343,526)
                                               -------------     -------------
Non-current portion                            $    159,572      $    343,922
                                               =============     =============

The following is a summary of fixed assets held under capital leases at June 30,
2009 and December 31, 2008:

                                               June 30, 2009   December 31, 2008
                                               -------------   -----------------
Medical Equipment                              $  1,022,674      $  1,026,017
Less: accumulated depreciation                     (403,532)         (376,977)
                                               -------------     -------------
Capital leased fixed assets, Net                    619,141           649,040

NOTE 7- OTHER PAYABLE

Other  payable  as of June 30,  2009  and  December  31,  2008  consists  of the
following:

                                        June 30,        December 31,
                                          2009             2008

         Advance from customers       $   7,041          $   5,397

         Welfare payable                 76,892             84,161

         Other payable                  111,327            261,941
         ----------------------------------------------------------------
         Total                        $ 195,260          $ 351,499
         ================================================================


                                       11
<PAGE>

NOTE 8- STOCKHOLDERS' EQUITY

Common Stock

As of June 30, 2009 and December 31, 2008, the Company has 100,000,000 shares of
common stock authorized with a par value of $0.001.

During the period ended December 31, 2008, the company issued 177,834 shares for
$77,780.and  cancelled  18,000  previously  issued shares  issued in error.  The
company  did not issue any shares  during the six month  periods  ended June 30,
2009.

The Company has not  granted  any options or warrants  during 2009 or 2008,  and
there are no options or warrants  outstanding  as of June 30, 2009 and  December
31, 2008.

Preferred Stock

As of June 30, 2009 and December 31, 2008, the Company has 20,000,000  shares of
preferred  stock  authorized  with a par  value of  $0.001.  There are no shares
issued and outstanding as of June 30, 2009.

Statutory Reserves

As  stipulated by the Company Law of the People's  Republic of China (PRC),  net
income after taxation can only be distributed as dividends  after  appropriation
has been made for the following:


i.    Making up cumulative prior years' losses, if any;

ii.   Allocations to the "Statutory  surplus reserve" of at least 10% of income
      after tax, as  determined  under PRC  accounting  rules and  regulations,
      until the fund amounts to 50% of the Company's registered capital;

iii.  Allocations  of 5-10% of  income  after  tax,  as  determined  under  PRC
      accounting  rules and  regulations,  to the Company's  "Statutory  common
      welfare  fund",  which  is  established  for  the  purpose  of  providing
      employee  facilities  and  other  collective  benefits  to the  Company's
      employees; and

iv.   Allocations  to the  discretionary  surplus  reserve,  if approved in the
      stockholders' general meeting.

Pursuant to the new  Corporate  Law  effective on January 1, 2006,  there is now
only one "Statutory surplus reserve"  requirement.  The reserve is 10 percent of
income after tax, not to exceed 50 percent of registered capital.

The Company did not  appropriate  reserve for the statutory  surplus reserve for
the six month periods ended June 30, 2009, and 2008.

NOTE 9- PROVISION FOR INCOME TAXES

In accordance  with the relevant tax laws and  regulations of PRC, the corporate
income tax rate is 25%. As noted, the corporate income tax for 2004 through 2006
was 0% due to the  Company's  receipt  of a  waiver  (tax  relief)  from the PRC


                                       12
<PAGE>

government as they acquired a previous  government-owned hospital and privatized
it and improved it. Commencing, 2008, the corporate tax rate will be 25%.

Income tax for the six month period  ended June 30, 2009 and 2008 is  summarized
as follows:

                                           2009         2008
                                         --------     --------

  U.S. Federal and State Current         $      -     $      -
  U.S. Federal and State Deferred               -            -
  PRC - Current                                 -            -
                                       -----------  -----------
  PRC - Deferred                                -       46,000
                                       -----------  -----------
   Less: Valuation allowance                    -      (46,000)
                                       -----------  -----------
Income tax expense (benefit)           $        -   $        -
                                       ===========  ===========

A reconciliation of the effective income tax rate is as follows:

                                             2009         2008
                                             ----         ----

Tax at U.S. Federal rate                     34%            34%

U.S. tax exemption                          (34)%          (34)%
                                          -------          -----
                                             0%              0%
PRC Tax rate                                 25%            25%
Valuation allowance                         (25)%          (25)%
Current tax provision                        0%             0%

The Company does not have any significant deferred tax asset or liabilities in
the PRC tax jurisdiction as of June 30,2009.

NOTE 10- RELATED PARTY TRANSACTIONS

Due from/to Related Parties

The Company has entered into  agreements  with Nanning Tongji Chain Pharmacy Co.
Ltd. and Guangxi Tongji Medicine Co. Ltd.  whereby the Company from time to time
will advance  amounts to assist them in their  operations.  The three  companies
have common major  shareholders.  The advanced amounts accrue interest at a rate
of 6% per annum.  The amount of  receivable as of June 30, 2009 and December 31,
2008 were $54,861 and $268,815.  Interest income for the six month periods ended
June 30, 2009 and 2008 were $0 and $35,266, respectively.

The Company has entered into an agreement with the Chairman and the  shareholder
of the Company whereby the Company from time to time will be advanced amounts to
assist them in their operations.  The advanced amounts accrue interest at a rate
of 6% per annum.  As of June 30, 2009 and  December 31,  2008,  $3,920,536,  and
$3,367,857  were  payable to their  Chairman,  shareholder  and  Guangxi  Tongji
Medicine Co. Ltd.  respectively.  Interest  expenses  for the six month  periods
ended June 30, 2009 and 2008 were $102,608 and $66,647, respectively.


                                       13
<PAGE>

Rental

The Company has entered into a lease  agreement for their  hospital with Guangxi
Tongji  Medicine Co. Ltd that expires  December  2008.  The Company  renewed the
lease for additional 5 years at monthly rate of $2,402 (RMB16,439). Based on the
exchange  rate at June 30, 2009,  minimum  future 5 years lease  payments are as
follows:


        2010                  $  28,820
        2011                     28,820
        2012                     28,820
        2013                     28,820
                              ----------
        Total                 $ 115,280



                                       14
<PAGE>

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operation

      You should read the following discussion and analysis of our financial
condition and results of operations in conjunction with our financial statements
and the related notes included elsewhere in this report. Our financial
statements have been prepared in accordance with U.S. GAAP. In addition, our
financial statements and the financial data included in this report reflect our
reorganization and have been prepared as if our current corporate structure had
been in place throughout the relevant periods. The following discussion and
analysis contains forward-looking statements that involve risks and
uncertainties. Actual results could differ materially from those projected in
the forward-looking statements.

                                    Overview

      We were organized as a Nevada corporation on December 19, 2006. On
December 27, 2006 we issued 15,652,557 shares of our common stock to acquire all
outstanding shares of Nanning Tongji Hospital Co., Ltd., which we refer to as
"Tongji Hospital," a PRC company which was formed in October 30, 2003. The
purpose of the transaction was to redomicile us as a Nevada corporation. Unless
otherwise indicated, all references to us throughout this report includes the
operations of Tongji Hospital.

      Our critical accounting policies, as well as recent accounting
pronouncements which apply to us, are described in Note 2 to our financial
statements which are included as part of this report.

Results of Operation

      Material changes of items in our Statement of Operations are discussed
below.

Three Months Ended June 30, 2009

      Patient Service Revenue decreased primarily as the result of road
construction near our hospital as well as the rainy season which reduced patient
visits.

     Other Operating Revenue increased slightly as the result of increased sales
of medicine to our patients.

     Operating Expenses:  Selling, General and Administrative expenses increased
primarily  due to the  higher  accounting  and  legal  expenses.  Our  costs for
Medicine and Supplies increased as the result of increased revenue from patients
for the three months ended June 30, 2009 as compared to the same period of prior
year.  An  increase  in the  reserve  for  bad  debts  during  the  period  also
contributed to higher operating expenses.


                                       15
<PAGE>



Six Months Ended June 30, 2009

     Patient  Service  Revenue  decreased   primarily  as  the  result  of  road
construction near our hospital which reduced patient visits.

     Other  Operating  Revenue  decreased as less  patients  were treated  which
contributed to the reduced sales of medicine during the period.

     Operating Expenses:  Selling, General and Administrative expenses increased
primarily due to increased  accounting  expenses and consulting  fees associated
with the  construction of our new hospital.  Our costs for Medicine and Supplies
decreased as the result of the decreased  sales of medicine.  An increase in the
reserve for bad debts  during the period also  contributed  to higher  operating
expenses.

Trends, Events and Uncertainties

      The China Ministry of Health, as well as other related agencies, have
proposed changes to the prices we can charge for medical services, drugs and
medications. We cannot predict the impact of these proposed changes since the
changes are not fully defined and we do not know whether those proposed changes
will ever be implemented or when they may take effect.

      In accordance with the relevant laws and regulations of PRC our income tax
rate is typically be 33%.

      We are required to pay a tax of 5% of the income derived from providing
medical treatment plus city construction and educational taxes equal to 7% and
3% respectively, of the business tax. We were exempt from these taxes in 2008.

     We are building a new 600-bed hospital in Nanning, China. We expect the new
hospital to be completed by January 2011. The hospital is being built by Guangxi
Construction  Engineering Group Corporation and, when completed,  will be leased
by us for a  twenty-year  term.  The lease  payment will be $381,000  during the
first year of the lease. The annual lease payments will gradually  increase each
year such that,  during the final year of the lease,  our lease payments will be
$801,783,  based upon current  exchange  rates.  Our agreement with Langdong 8th
Group requires us to make payments of  approximately  $5,600,000 to Langdong 8th
Group  during  the  construction  phase.  As  of  June  30,  2009  we  had  paid
approximately $3,960,000 towards this amount.

      Other than the factors listed above we do not know of any trends, events
or uncertainties that have had or are reasonably expected to have a material
impact on our net sales or revenues or income from continuing operations. Our
business is not seasonal in nature.



                                       16
<PAGE>


Accounting Estimates

      In the United States most hospitals have contracts with health insurance
companies which provide that patients with health insurance will be charged
reduced rates for healthcare services. Reduced rates are also charged for
Medicare and Medicaid patients. Although the patient is billed for the services
provided by the hospital at the higher rate normally charged to patients without
insurance the amount billed is reduced by the charges paid by the insurance
carrier and by the difference (sometimes known as the "contractual allowance")
between the normal rate for the services and the reduced rate which the hospital
estimates it will receive from Medicare, Medicaid and insurance companies.

      For financial reporting purposes, hospitals in the United States record
revenues based upon established billing rates less adjustments for contractual
allowances. Revenues are recorded based upon the estimated amounts due from the
patients and third-party payors, including federal and state agencies (under the
Medicare and Medicaid programs) managed care health plans, health insurance
companies, and employers. Estimates of contractual allowances under third-party
payor arrangements are based upon the payment terms specified in the related
contractual agreements. Third-party payor contractual payment terms are
generally based upon predetermined rates per diagnosis, per diem rates, or
discounted fee-for-service rates.

      Due to the complexities involved in determining amounts ultimately due
under reimbursement arrangements with a large number of third-party payors,
which are often subject to interpretation, the reimbursement actually received
by U.S. hospitals for health care services is sometimes different from their
estimates.

      The medical system in China is different than that in the United States.
Private medical insurance is not generally available to the Chinese population
and as a result services and medications provided by our hospital are usually
paid for in cash or by the Medicare agencies of the Nanning municipal government
and the Guangxi provincial government. Our billing system automatically
calculates the reimbursements to which we are entitled based upon regulations
promulgated by the Medicare agencies. We bill the Medicare agencies directly for
services provided to patients coved by the Medicare programs. Since we bill the
Medicare agencies directly, our gross revenues are not reduced by contractual
allowances.

      Since we only deal with the Nanning municipal and the Guangxi provincial
Medicare agencies we are familiar with their regulations pertaining to
reimbursements. As a result, there is normally no material difference between
the amounts we bill and the amounts we receive for services provided to Medicare
patients.

Liquidity and Capital Resources
-------------------------------

     Refer to the  Consolidated  Statements  of Cash  Flows  included  with this
report for  information  concerning  our sources and uses of cash during the six
months ended June 30, 2009.

                                       17
<PAGE>

     Future payments due on our material contractual  obligations as of June 30,
2009 are as follows:

<TABLE>
<S>                         <C>        <C>        <C>        <C>         <C>         <C>       <C>

Item                       Total      2009       2010        2011        2012        2013   Thereafter
----                       -----      ----       ----        ----        ----        ----   ----------

Medical Building Lease  $  113,572  $   --   $  28,393   $  28,393   $  28,393   $  28,393   $    --
Capital Leases          $  336,167  $   --   $ 336,167          --          --          --   $    --
Lease on New Hospital   $1,187,248  $   --          --   $ 381,092   $ 395,749   $ 410,407   $    --
</TABLE>

     Except as shown  above,  as of June 30,  2009 we did not have any  material
capital requirements.

     Income from our  operations  has been, and is expected to be in the future,
our primary source of cash.

     We do not have any  off-balance  sheet  items  reasonably  likely to have a
material effect on our financial condition.

Item 4.  Controls and Procedures.

     (a) Tongji maintains a system of controls and procedures designed to ensure
that  information  required to be disclosed in reports filed or submitted  under
the  Securities  Exchange Act of 1934,  as amended  ("1934  Act"),  is recorded,
processed,  summarized and reported,  within time periods specified in the SEC's
rules and forms and to ensure  that  information  required  to be  disclosed  by
Tongji  in the  reports  that it  files  or  submits  under  the  1934  Act,  is
accumulated  and  communicated to Tongji's  management,  including its Principal
Executive  Officer and Principal  Financial  Officer,  as  appropriate  to allow
timely decisions  regarding required  disclosure.  As of June 30, 2009, Tongji's
Principal  Executive  Officer and  Principal  Financial  Officer  evaluated  the
effectiveness  of the design and operation of Tongji's  disclosure  controls and
procedures.  Based on that  evaluation,  the  Principal  Executive  Officer  and
Principal  Financial  Officer  concluded that Tongji's  disclosure  controls and
procedures were effective.

     (b)  Changes in  Internal  Controls.  There  were no  changes  in  Tongji's
internal  control over  financial  reporting  during the quarter  ended June 30,
2009, that materially  affected,  or are reasonably likely to materially affect,
its internal control over financial reporting.

                                     PART II
Item 6.  Exhibits

Exhibits

  31.1  Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  31.2  Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  32    Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



                                       18
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                     TONGJI HEALTHCARE GROUP, INC.


August 13, 2009                      By: /s/ Yun-hui Yu
                                         -------------------------------------
                                         Yun-hui Yu, Principal Executive Officer


August 13, 2009                      By: /s/ Wei-dong Huang
                                         -------------------------------------
                                         Wei-dong Huang, Principal Financial and
                                         Accounting Officer